Triphosphate

Triphosphate

SCHEMBL4186099

O=P(O)(O)OP(=O)(O)OP(=O)(O)O.Oc1cc(O)cc(O)c1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8

The experimentally established mechanism targets of Triphosphate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.45
BLM P54132 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
BACE1 P56817 1/20 0.42
INPPL1 O15357 4/20 0.40
INPP5A Q14642 2/20 0.40
INPP5B P32019 1/20 0.40
LCK P06239 1/20 0.38
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA7 P43166 2/20 0.35
CA9 Q16790 2/20 0.35
CA14 Q9ULX7 2/20 0.35
BTN3A1 O00481 2/20 0.34
CA5A P35218 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyrophosphoric Acid SCHEMBL4179033 0.89 FDPS (0.59) FDPSBLMTDP1BACE1INPPL1
SCHEMBL4181918 0.85 INPPL1 (0.45) FDPSBLMTDP1BACE1INPPL1
SCHEMBL4179021 0.84 INPPL1 (0.48) FDPSBLMTDP1BACE1INPPL1
Resorcinol SCHEMBL27885652 0.84 CA12 (0.50) FDPSBLMTDP1INPPL1INPP5A
Triphosphate SCHEMBL18714 0.80 FDPS (0.69) FDPSBLMTDP1INPPL1INPP5A
Triphosphate SCHEMBL15555988 0.80 FDPS (0.69) FDPSBLMTDP1INPPL1INPP5A
SCHEMBL4181366 0.78 FDPS (0.50) FDPSBLMTDP1INPPL1INPP5A
Triphosphate SCHEMBL25284822 0.76 FDPS (0.64) FDPSBLMTDP1BTN3A1
Triphosphate SCHEMBL3253186 0.76 FDPS (0.64) FDPSBLMTDP1BTN3A1
Triphosphate SCHEMBL9632051 0.76 FDPS (0.64) FDPSBLMTDP1BTN3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090098589-A1 Method DUPONT NUTRITION BIOSCIENCES APS (DK) 2009-04-16 US claimed
JP-2008545385-A 2008-12-18 JP claimed
EP-1888771-A2 METHOD FOR DETERMINING PHYTASE ACTIVITY DANISCO A/S (DK) 2008-02-20 EP claimed
WO-2006123254-A2 METHOD FOR DETERMINING PHYTASE ACTIVITY DANISCO A/S (DK) 2006-11-23 WO claimed
CN-117222705-A Thermosetting composition, method for producing molded article using same, and cured article 出光兴产株式会社 2023-12-12 CN disclosed
CN-117178003-A Thermosetting composition for injection molding, method for producing molded article using the composition, and cured article 出光兴产株式会社 2023-12-05 CN disclosed
CN-117120494-A Thermosetting composition, method for producing molded article using same, and cured article 出光兴产株式会社 2023-11-24 CN disclosed
CN-117098787-A Thermosetting composition for injection molding, method for producing molded article using the composition, and cured article 出光兴产株式会社 2023-11-21 CN disclosed
US-20090098589-A1 Method DUPONT NUTRITION BIOSCIENCES APS (DK) 2009-04-16 US disclosed
CN-101175861-A Method DANISCO (DK) 2008-05-07 CN disclosed
EP-1888771-A2 METHOD FOR DETERMINING PHYTASE ACTIVITY DANISCO A/S (DK) 2008-02-20 EP disclosed
WO-2006123254-A2 METHOD FOR DETERMINING PHYTASE ACTIVITY DANISCO A/S (DK) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090098589-A1 Method ALPL, PPA1, ITPA FDPS 176/4885BLM 3653/4885TDP1 1661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.